We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Exelixis
EXEL
$12.6B
| $2.4M | 0.01% |
72,066
-6,400
| -8% | -$208K |
|
|
SKX
602
DELISTED
Skechers
SKX
| $2.4M | 0.01% |
35,690
-1,000
| -3% | -$64.9K |
|
603
Crown Holdings
CCK
$13B
| $2.4M | 0.01% |
29,000
| – | – |
|
604
Globe Life
GL
$14.1B
| $2.4M | 0.01% |
21,500
| – | – |
|
605
Webster Financial
WBS
$12.8B
| $2.4M | 0.01% |
43,393
| – | – |
|
606
Fabrinet
FN
$20.3B
| $2.39M | 0.01% |
10,866
+1,900
| +21% | +$458K |
|
607
Generac Holdings
GNRC
$12.8B
| $2.37M | 0.01% |
15,300
-100
| -0.6% | -$17.3K |
|
608
Teleflex
TFX
$5.77B
| $2.37M | 0.01% |
13,300
-600
| -4% | -$123K |
|
609
Aramark
ARMK
$16.1B
| $2.36M | 0.01% |
63,300
+4,800
| +8% | +$187K |
|
610
Globant
GLOB
$1.77B
| $2.36M | 0.01% |
11,000
-800
| -7% | -$175K |
|
611
TD Synnex
SNX
$20.3B
| $2.35M | 0.01% |
20,042
-2,100
| -9% | -$251K |
|
612
Domino's
DPZ
$11.7B
| $2.34M | 0.01% |
5,569
+291
| +6% | +$127K |
|
613
Houlihan Lokey
HLI
$9.08B
| $2.34M | 0.01% |
13,458
+1,300
| +11% | +$229K |
|
614
Knight Transportation
KNX
$12B
| $2.33M | 0.01% |
44,000
-1,900
| -4% | -$103K |
|
615
Donaldson
DCI
$11.1B
| $2.32M | 0.01% |
34,432
+1,300
| +4% | +$95.9K |
|
|
GTLS
616
DELISTED
Chart Industries
GTLS
| $2.32M | 0.01% |
12,134
| – | – |
|
617
Samsara
IOT
$23.9B
| $2.32M | 0.01% |
53,000
+6,000
| +13% | +$295K |
|
618
Solventum
SOLV
$14.7B
| $2.31M | 0.01% |
+35,000
| New | +$2.45M |
|
619
Everest Group
EG
$14.1B
| $2.31M | 0.01% |
6,368
+3,982
| +167% | +$1.49M |
|
620
CAVA Group
CAVA
$8.36B
| $2.3M | 0.01% |
20,400
+9,800
| +92% | +$1.31M |
|
621
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $2.3M | 0.01% |
20,095
+5,200
| +35% | +$586K |
|
622
Huazhu Hotels Group
HTHT
$12.5B
| $2.3M | 0.01% |
69,576
+2,572
| +4% | +$93.1K |
|
623
Charles River Laboratories
CRL
$13.4B
| $2.3M | 0.01% |
12,437
+200
| +2% | +$38.5K |
|
624
Fortune Brands Innovations
FBIN
$5.8B
| $2.3M | 0.01% |
33,600
-500
| -1% | -$40.1K |
|
625
Bath & Body Works
BBWI
$3.79B
| $2.29M | 0.01% |
59,149
+5,400
| +10% | +$181K |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.